Chlamydia pneumoniae Infection in Atherosclerotic Lesion Development through Oxidative Stress: A Brief Overview

The Elusive but Pathogenic Peptidoglycan of Chlamydiae

(2017) M. Di Pietro et al.   European Journal of Inflammation

Oxidative stress in vascular disease and its pharmacological prevention

(2013) Huige Li et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis

(2012) Simone Kreutmayer et al.   CELL STRESS & CHAPERONES

Transcription factor complex AP-1 mediates inflammation initiated byChlamydia pneumoniaeinfection

(2012) Anyou Wang et al.   CELLULAR MICROBIOLOGY

Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease

(2012) Kai Chen et al.   Current Atherosclerosis Reports

Platelets: key players in vascular inflammation

(2012) Delia Projahn et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Chlamydophila (Chlamydia) pneumoniae infection promotes vascular smooth muscle cell adhesion and migration through IQ domain GTPase-activating protein 1

(2012) Lijun Zhang et al.   MICROBIAL PATHOGENESIS

Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?

(2012) M. Di Pietro et al.   OSTEOPOROSIS INTERNATIONAL

GroEL1, from Chlamydia pneumoniae, Induces Vascular Adhesion Molecule 1 Expression by p37AUF1 in Endothelial Cells and Hypercholesterolemic Rabbit

(2012) Chun-Yao Huang et al.   PLoS One

Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells

(2011) M. N. Chahine et al.   CARDIOVASCULAR RESEARCH

Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species

(2011) Jennifer Rivera et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

GroEL1, a Heat Shock Protein 60 of Chlamydia pneumoniae , Induces Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Expression in Endothelial Cells and Enhances Atherogenesis in Hypercholesterolemic Rabbits

(2011) Feng-Yen Lin et al.   JOURNAL OF IMMUNOLOGY

Chlamydia pneumoniae Induces Chemokine Expression by Platelets in Patients with Atherosclerosis

(2011) Abdelhad Al-Bannawi et al.   MEDICAL PRINCIPLES AND PRACTICE

Chlamydia persistence – a tool to dissect chlamydia–host interactions

(2011) R.V. Schoborg   MICROBES AND INFECTION

NOX Isoforms and Reactive Oxygen Species in Vascular Health

(2011) R. M. Touyz et al.   MOLECULAR INTERVENTIONS

Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis

(2011) Lee Ann Campbell et al.   THROMBOSIS AND HAEMOSTASIS

Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells followingChlamydia pneumoniaeinfection and its down-regulation by fluvastatin

(2010) D. Prochnau et al.   ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Critical Role of the Nitric Oxide/Reactive Oxygen Species Balance in Endothelial Progenitor Dysfunction

(2010) Felix Fleissner et al.   ANTIOXIDANTS & REDOX SIGNALING

Is oxidative stress a therapeutic target in cardiovascular disease?

(2010) Thomas Münzel et al.   EUROPEAN HEART JOURNAL

Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis

(2010) Justin F. Deniset et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Chlamydia pneumoniaeHeat Shock Protein 60 Enhances Expression of ERK, TLR-4 and IL-8 in Atheromatous Plaques of Coronary Artery Disease Patients

(2010) Hem C. Jha et al.   IMMUNOLOGICAL INVESTIGATIONS

IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice

(2010) S. Chen et al.   JOURNAL OF IMMUNOLOGY

Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways

(2010) Wei Liu et al.   MICROBES AND INFECTION

Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke

(2010) Berna Atik et al.   PLoS One

Basic Science Review Section: Statin Therapy—Part II: Clinical Considerations for Cardiovascular Disease

(2010) Benjamin Sadowitz et al.   Vascular and Endovascular Surgery

Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected withChlamydia (Chlamydophila) pneumoniae 

(2009) M. HÖGDAHL et al.   APMIS

Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients

(2009) HEM C. JHA et al.   APMIS

Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells

(2009) C. Chen et al.   CARDIOVASCULAR RESEARCH

Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes

(2009) Sabina A. Murphy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR α and PPAR γ-dependent pathways

(2008) Chun-li Mei et al.   CELL BIOLOGY INTERNATIONAL

The transcript profile of persistentChlamydophila(Chlamydia)pneumoniae in vitrodepends on the means by which persistence is induced

(2008) Andreas Klos et al.   FEMS MICROBIOLOGY LETTERS

Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease

(2008) Hem Chandra Jha et al.   Journal of Cardiology

Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells

(2008) Anna Oksaharju et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A: cholesterol acyltransferase 1

(2008) Ping He et al.   MICROBES AND INFECTION